Of the 416 subjects screened, 335 were randomly assigned to receive treatment and one subject withdrew; therefore, 334 subjects received treatment (of whom 312 were evaluable for efficacy) and 303 ...

Overview: Insulin glargine is a long-acting insulin used to lower blood sugar levels in people with diabetes. It helps get sugar into your cells, so your body can use it for energy. The most common ...

The FDA has granted breakthrough device designation for an implantable insulin pump designed for people with type 1 diabetes, according to an industry press release. The implantable device (Portal ...

Regular insulin, which is often used in pregnancy for the treatment of diabetes, has some drawbacks: it starts its action from 30 to 60 min after subcutaneous injection and it peaks too late (2-3 h ...

Dr. Kaitlyn R. Shank (Medicine): A 46-year-old woman was admitted to this hospital because of hyperglycemia that was refractory to insulin therapy. Five years before the current presentation, the ...

Merilog, a biosimilar to Novolog, offers a more affordable insulin option for type 2 diabetes patients, enhancing treatment accessibility. The GEMELLI-1 trial confirmed Merilog's noninferiority to the ...

Please provide your email address to receive an email when new articles are posted on . A revised technosphere insulin label recommends patients start using the therapy at a higher dose than ...

"By expanding to Android, we're broadening our reach to bring the benefits of Tandem Mobi to even more people living with diabetes," said John Sheridan, president and chief executive officer. "It's an ...